O-GlcNAcylation at the center of antitumor immunity
Open Access
- 18 October 2023
- journal article
- review article
- Published by Elsevier in Current Opinion in Biotechnology
- Vol. 84, 103009
Abstract
No abstract availableKeywords
Funding Information
- Nederlandse Organisatie voor Wetenschappelijk Onderzoek
This publication has 55 references indexed in Scilit:
- STAT3 and STAT6 Signaling Pathways Synergize to Promote Cathepsin Secretion from Macrophages via IRE1α ActivationCell Reports, 2016
- Regulation of OGT by URI in Response to Glucose Confers c-MYC-Dependent Survival MechanismsCancer Cell, 2016
- Epithelial Mesenchymal Transition Induces Aberrant Glycosylation through Hexosamine Biosynthetic Pathway ActivationJournal of Biological Chemistry, 2016
- Glucose and glutamine fuel protein O-GlcNAcylation to control T cell self-renewal and malignancyNature Immunology, 2016
- CD45 Phosphatase Inhibits STAT3 Transcription Factor Activity in Myeloid Cells and Promotes Tumor-Associated Macrophage DifferentiationImmunity, 2016
- O-GlcNAcylation of G6PD promotes the pentose phosphate pathway and tumor growthNature Communications, 2015
- Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer ProgressionCell, 2015
- Phosphoenolpyruvate Is a Metabolic Checkpoint of Anti-tumor T Cell ResponsesCell, 2015
- T Cell Exit from Quiescence and Differentiation into Th2 Cells Depend on Raptor-mTORC1-Mediated Metabolic ReprogrammingImmunity, 2013
- Phosphoinositide signalling links O-GlcNAc transferase to insulin resistanceNature, 2008